Clinical Research Directory
Browse clinical research sites, groups, and studies.
Development of a Pharmacodynamic Model for Propofol in Older Adults
Sponsor: Pontificia Universidad Catolica de Chile
Summary
The goal of this pharmacodynamic study is to develop a model for Propofol administration for older adults (\>65 years). The main objective is to create a model based on a new pharmacodynamic parameter, derived from frontal electroencephalogram (EEG), to admininster Propofol in older adults. With this new model, the investigators aim to: * Evaluate the relationship between the plasmatic concentration, described by the Eleveld pharmacokinetic model, versus the effect of the drug represented with a new parameter derived from the intraoperative frontal EEG. * To validate the predictive ability of Eleveld's pharmacokinetic-pharmacodynamic model, based on the bispectral index (BIS), compared to the new model based on a parameter derived from intraoperative frontal EEG. Participants will be asked to answer preoperative questionnaires, receive a Propofol intravenous infusion concomitantly with continuous BIS and EEG monitoring, and to be evaluated for clinical sings of loss and return of consciousness.
Official title: Development of a Pharmacodynamic Model for Propofol in Older Adults (Development phaRmacodynamic mOdel Propofol oLdEr adulTs: DROPLET)
Key Details
Gender
All
Age Range
65 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-06-01
Completion Date
2025-08-01
Last Updated
2025-05-31
Healthy Volunteers
No
Conditions
Interventions
Propofol
Patients older than 65 years of age will receive an intravenous infusion of Propofol with prespecified plasma targets. During its administration, registration of BIS values, frontal electroencephalography, and clinical signs of consciousness will be performed.
Locations (1)
Pontificia Universidad Católica de Chile
Santiago, Santiago Metropolitan, Chile